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(PPi) is considered as a 
diagnostic marker for 
various diseases such as 
cancer and vascular 
calcification. It plays also 
an important preservative 
role as an additive E450 in 
foodstuff. In this work, we describe a novel selective FeIII-salen based probe for PPi, which 
disassembles in the presence of the target analyte into its molecular blocks, 1,2-propanediamine 
and 3-chloro-5-formyl-4-hydroxybenzenesulfonic acid. The latter signaling unit leads to a 
fluorometric response. Compared to a related prototype, the new complex shows a 2.3-times 
stronger emission at 500 nm and a 155-times better selectivity of PPi over ATP. Importantly, 








Phosphates are ubiquitous in biological systems. They are encountered as mono- and poly-
anions as well as building blocks in natural products such as nucleic acids, adenosine 
triphosphate (ATP) and vitamin B12.
1, 2 Related to their diverse molecular structures, this class 
of compounds exhibits important biological roles in energy storage and signal transduction 
processes.3, 4 One member of this important class of compound is inorganic pyrophosphate (PPi; 
P2O7
4-).5 It is produced from nucleoside triphosphates in various biological transformations 
including the hydrolysis of ATP, the syntheses of DNA as well as of small molecular 
metabolites.5, 6 Considering the broad occurrence of (polyoxo)phosphates in biological systems, 
they are also encountered as natural composites in food. In addition to their natural occurrence, 
this class of compounds is also legally added to foodstuff as preservative, emulsifier or taste 
intensifier.7 In the European Union and Switzerland, the use of PPi as food additive E450 is not 
restricted and PPi is found in high concentrations in products such as canned meat, fish and 
bakery products.8 Although the dietary intake of naturally occurring (polyoxo)phosphates does 
not represent a risk for healthy people,9 the increasing use of phosphate salts as food additives 
exposes risks to people with renal disorders and cardiovascular diseases.8, 10, 11 For this reason, 
the restriction of dietary phosphate is recommended for patients with chronic renal failures for 
many years.8, 10, 11  
 
Figure 1: Examples of fluorogenic probes for PPi detection.12-14  
All of these examples underscore the importance to monitor (polyoxo)phosphates in the 
environment, biological systems and foodstuff. In this line, the development of straightforward 
selective and sensitive probes for PPi has attracted considerable attention.1, 15-17 The most 
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common sensing strategies are probably the chemosensing and displacement approaches for 
colorimetric as well fluorometric PPi detection.18 In 1994, Czarnik reported on the fluorometric 
detection of PPi with a polyamine modified anthracene derivative in H2O.
19 The Kataev group 
described the encapsulation and detection of PPi with an azacryptand based receptor (Figure 1, 
right).14 Probably the first example of discrimination of PPi over ATP was reported in 2004 by 
Hong and coworkers using a binuclear ZnII-bis(2-pyridylmethyl)amine complex. This system 
showed an approximate 5-fold fluorescence enhancement upon binding of PPi compared to 
ATP.20-22 Recently, a similar relative increase in emission intensity was observed for an aspartic 
acid-functionalized perylene diimide CuII-aggregate in the presence of PPi over ATP (~ 4-
fold).23 Despite the large number of PPi sensors described so far in the literature,24-26 only few 
detect endogenous PPi in biological media. Rissanen`s terpyridine-ZnII complex (Figure 1, left) 
is one of the rare exceptions.12 Our group contributed to this area with ZnII-, and FeIII-salen 
complexes as disassembly probes for PPi (Figure 1, middle).13, 27-30 Herein, we report on a new 
FeIII-salen complex 3 as reaction based sensor31-34 with improved sensitivity and selectivity for 
PPi (Scheme 1) and demonstrate its applicability for detecting PPi as E450 in baking powder. 
Remarkably, a single methyl group at the ethylene diamine backbone of the probe led to a 155 
times enhanced selectivity of PPi over ATP.  
Concept: 
The structures of the FeIII-salen based probes 1-4 are shown in Scheme 1. We envisaged that 
probes 2-4 would disassemble in the presence of PPi to their molecular building blocks 
according to the mechanism depicted in Scheme 1. Initially, PPi extracts the central FeIII-ion 
from the probes (“unlocking”). The metal-free tetradentate ligands 6-8 then hydrolyse to the 
diamine subunit and the fluorescent salicylaldehyde derivative 10 (“disassembly”). In short, 
“unlocking” of the FeIII-salen based probes (“locked complexes”) transduces PPi into a 




Scheme 1: Structures of the FeIII-probes 1-4 and its disassembly to the fluorescent 
salicylaldehyde derivatives 9, 10 in the presence of PPi. 
 
This mode of PPi detection was previously demonstrated with prototype 1 releasing the 
signaling unit 9.27 Unfortunately, this reaction-based probe exhibits several drawbacks. In 
particular, the sensitivity of 1 for PPi was rather poor. This undesired behavior is attributed to 
the weak fluorescence of 9 (Φ = 0.13 in DMF).35 To overcome this limitation, we decided to 
synthesize probes 2-4 with a more fluorescent signaling subunit 10 instead of 9. This derivative 
contains a chloro instead of a hydrogen substituent at position C3 of the salicylaldehyde moiety. 
This subtle, but important change leads to a 2.7-fold increase in quantum yield of the signaling 
unit 10 (Φ = 0.35 in DMF) compared to 9.35 In addition, we speculated also to implement 
additional modifications into the ethylenediamine backbone of 2 for fine-tuning the selectivity 
and reactivity of the probes. For this purpose, we chose to decorate 3 with an additional, electron 
donating methyl group in the ethylenediamine subunit and decided to replace the latter with a 
phenylenediamine building block in compound 4.  
Synthesis of FeIII-probes: Prototype 1 with the signaling unit 9 was synthesized as described 
previously.36 The signaling unit 3-chloro-5-formyl-4-hydroxybenzenesulfonic acid 10 was 
prepared as its sodium salt in three steps in 48 % yield according to literature procedures.37 
Afterward, this building block was condensed in EtOH/H2O (4:1) with either ethylenediamine, 
1,2-propanediamine or phenylenediamine to give ligands 6-8 in good yields (yields: 75-83%). 
The corresponding FeIII-complexes 2-4 were then obtained by complexation of the ligands with 
FeCl3 (yields: 83-88%). The synthetic route for the preparation of 3 is schematically depicted 




Scheme 2. Synthesis of the FeIII-probe 3 from the signaling unit 10 and 1,2-propanediamine. 
In the high-resolution mass spectrum of 3, the [MNa-H2O]2- ion was observed at m/z 
280.93908, corresponding to the molecular formula C17H12Cl2FeN2O8S2
2- (m/zcalc 280.93862). 
This behavior suggests that FeIII is reduced to FeII during mass spectrometric analysis. The 
absorption spectrum of 3 in H2O (pH 5, [Robinson buffer] = 10 mM) exhibits maxima at 310, 
395 and 500 nm. The latter maximum was assigned to a ligand-to-metal-charge transfer 
(LMCT) band and showed reversible changes with variations in pH (Figure S1). The pKa of the 
FeIII-bound water of 3 was determined as 6.9 (Figure S2).  
 
 
Figure 2: Structure of the FeIII-probe 11 (left) and its X-ray crystal structure (right). Ellipsoidal 
plot with a probability of 50%. One out of two molecules in the asymmetric unit is shown. 
Disorder in the propylene linker moiety is omitted for clarity.  
This behavior is in agreement with related square-pyramidal FeIII-complexes containing an 
apical aqua ligand.38-47 Further structural information was obtained from crystal structure 
analysis. Since all our attempts failed to crystallize complex 3, we decided to prepare the related 
hydrophobic ferric chloride - complex 11 (Figure 2 left). This derivative contains a chlorido 
instead of an aqua ligand at the metal center and lacks the sulfonate functionalities in the 
salicyaldehyde subunit compared to 3. Compound 11 was successfully crystallized from 
MeOH/ hexane using the layering method48 and structural analysis supported the square 
pyramidal coordination geometry of the complex (Figure 2 right, Figure S3, Tables S1, S2). 




Transformations of the Probes in the Presence of PPi: 
We tested the disassembly of the probes 2-4 (16 μM) with PPi (10 equiv) using UV-Vis and 
fluorescence spectroscopy. Addition of the target analyte PPi to the probes led to the formation 
of a new absorption band at 385 nm (Figure S10 left) and to a 2.4 and 3.5-fold enhanced 
fluorescence emissions at 500 nm for 2 and 3 (Figure S10 right), respectively.  
 
 
Figure 3. Left: Fluorescence spectra of 1 (16 μM) and 3 (16 μM) before and after addition of 
PPi (10 equiv; incubation time: 30 min; ex (1) = 350 nm, ex (3) = 385 nm) at pH 7.4 ([Tris 
buffer] = 10 mM). Right: Change in fluorescence intensity of 3 in the presence of PPi (0-500 
μM ) at 500 nm. Inset: Corresponding calibration curve (3 (16 μM), PPi (0-75 μM); LOD = 
1.50 μM, R2 = 0.991). 
These spectral changes are attributed to the PPi-induced liberation of the signaling unit 10 from 
2 and 3 (Figure S11). This behavior was also confirmed for the disassembly of 3 by mass 
spectrometric methods indicating the formation of 10 ([Ma]-: m/z 234.94741, m/zcalc 
234.94730) (Figure S12). In comparison to the disassembly of prototype 1 with PPi (10 equiv), 
the reaction with 3 leads to a 2.3-times stronger emission and a red shift (10 nm) of the emission 
maximum (Figure 3 left). This significant improvement is in line with the release of the 2.7-
times more fluorescent signaling unit 10 instead of 9 from the “locked” FeIII-salen complexes. 
A calibration curve was generated from titrations of 3 (16 μM) with increasing concentrations 
of PPi (0-500 μM) indicating that quantifications are possible in the linear range between 0 and 
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75 μM of PPi with a limit of detection (LOD) of 1.50 μM (Figure 3 right). In contrast to the 
reactivity of probes 3 and 2, complex 4 did not show any tendency to disassemble in the 
presence of PPi (Figure S13). Apparently, the strong electron donating character of the 
phenylenediamine backbone enhances coordination of the FeIII-ion and impedes thereby the 




The selectivity of the FeIII-complexes 2 and 3 for PPi was tested subsequently with sixteen 
frequently encountered anions including the phosphate ions ATP and PO4
3- (Figures 4, S14 and 
S15). Complex 2 showed unfortunately a 1.4-fold and 1.2-fold increase in fluorescence at 500 
nm in the presence of ATP and PO4
3- (Figure S14 right).  
   
 
Figure 4. Left: Fluorescence spectra of 3 (16 μM, ex = 385 nm) in the presence of PPi (10 
equiv) and 16 different anions (10 equiv; see right for details; incubated for 30 min) at pH 7.4 
([Tris buffer] = 10 mM). Right: Normalized change in fluorescence intensity of 3 (16 µM, ex 
= 385 nm) at 500 nm in the presence of PPi (10 equiv) and different anions (10 equiv) at pH 
7.4 ([Tris buffer] = 10 mM) (A: AMP, B: ADP, C: ATP, D: PPi, E: PO4
3-, F: CN-, G: F-, H: Cl-




-, O: SCN- and P: HCO3
-). 
 
This lack of selectivity was significantly improved with probe 3. This fluorescent probe for PPi 
showed – in contrast to 2 - no disassembly with all other anions including ATP and PO43- 
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(Figure S15, Figure 4). The selectivity of 3 for PPi in the presence of other potentially 









Figure 5. Fluorescence intensity at 500 nm of 3 and 2 (16 μM; ex = 385 nm) in the absence 
and presence of PPi, ATP and PO4
3- (10 equiv; incubated for 30 min) at pH 7.4 ([Tris buffer] = 
10 mM). 
In comparison to complex 2, compound 3 with an additional methyl group in the 
ethylenediamine backbone of the salen ligand exhibited a remarkable improved selectivity of 
PPi over ATP (~ 130 fold) and PO4




The disassembly reaction of 3 to the signaling unit 10 in the presence of PPi (Scheme 1) was 
supported by 1H-NMR studies in D2O and mixtures of DMSO-d6 and D2O. Addition of PPi (10 
equiv) to a solution of 3 (2 mM) at pD 7.4 ([Tris buffer] = 10 mM) showed in the 1H-NMR 
spectra the formation of 10 within 30 min (Figure S16). Remarkably, we did not observe any 
signals from the metal-free ligand 7 in the reaction mixtures. This behavior suggests that upon 
extraction of FeIII from 3 with PPi, the subsequent hydrolysis of 7 with H2O is fast on the NMR 
time scale. In contrast, we were able to observe the formation of 7 when we demetalled 3 with 
PPi in DMSO-d6 (Figure 6). This time, two singlets at 8.60 ppm and 8.65 ppm (Figure 6) were 
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observed corresponding to the protons (labeled as a and a’, respectively) of the imine moiety 
of 7. Hydrolysis of the latter to the signaling unit 10 was only observed after adding increasing 
amounts of D2O (5-15 μL) to the reaction mixture (Figure 6: lines 3-5). Evidence for 
interactions of FeIII with the bidentate chelator PPi was also obtained by 31P NMR indicating a 
















Figure 6. Top: Scheme for the reaction of 3 with PPi to form the salicylaldehyde derivative 10. 
Bottom: 1H NMR spectra of 3 (2 mM, in DMSO-d6) in the absence [line 1] and presence of PPi 
(10 equiv) in DMSO-d6 [line 2]. Lines 3 to 5: Addition of increasing amounts of D2O (5, 10 
and 15 μL) to the reaction mixture depicted in line 2. Line 6 corresponds to a solution of 10 in 




Kinetics of the disassembly of 3 with PPi was determined by UV/Vis spectroscopy. When PPi 
(20 equiv) was added to a solution of 3 (16 M) in H2O at pH 7.4 ([Tris] = 10 mM) at 25 oC, 
clean conversion to 10 within 50 min was observed by monitoring spectroscopically changes at 
385 nm. A monoexponential fit (R2= 0.992) yielded a pseudo-first-order rate constant (kobs) of 
0.0567 ± 8.7084×10-4 min-1 with a half-life time (t1/2) of 12 min (Figure 7). This rate is about 
44 times faster than self-hydrolysis of 3 in the absence of any analyte at pH 7.4 at 25 oC (kobs = 
0.0013 ± 1.3038×10-5 min-1, t1/2 = 533 min) (Figure S18). The stability of the complex 3 was 
studied from pH 5.5 to 10.5 demonstrating that the complex is less susceptible to self-hydrolysis 
at lower pH (Table S3). In contrast, disassembly of 3 in the presence of ATP (20 equiv) at pH 
7.4 at 25 oC is only 2.8 times faster than background hydrolysis (kobs = 0.0036 ± 2.4201×10
-5 
min-1, t1/2 = 193 min) (Figure S19). We assign this behavior to mainly two factors. On the one 
hand, to a higher charge density of PPi over ATP and on the other hand to a subtle, but important 
entropic stabilization of 3 against demetallation. We are currently performing additional 
detailed mechanistic studies to explicitly unravel this important effect. 
Figure 7. Left: Spectral changes of 3 (16 μM) in the presence of PPi (20 equiv) with time at pH 
7.4 ([Tris buffer] = 10 mM) Right: Change in absorbance of 3 in the presence of PPi (20 equiv) 









Sensing of PPi in foodstuff and biological samples 
The applicability of compound 3 for sensing PPi was tested in foodstuff and biological samples. 
In a proof-of-principle study, we chose to detect PPi alias E450 in baking powder. The latter 
contains additionally NaHCO3
 and starch. Addition of an aqueous sample of baking powder to 
compound 3 at pH 7.4 ([Tris] = 10 mM) led to an increase of fluorescence at 500 nm suggesting 
the detection of E450 (Figure 8). This observation was supported by control experiments with 
HCO3









Figure 8. Left: Detection of PPi with 3 (16 μM) in an aqueous baking powder solution using a 
laboratory UV lamp. Right: Increase of fluorescence upon addition of an aqueous baking 
powder solution to 3 (16 μM, ex = 385 nm). Inset: Comparison of fluorescence intensities of 3 
in the absence and presence of baking powder as well as in the presence of PPi (200 μM).  
 
In addition we tested also the applicability of 3 for sensing PPi in HeLa (human cervix 
adenocarcinoma) cell line. A luminescent cell viability assay (CellTiter Glo®) indicated no 
cytotoxic effects upon treatment of cells for 1h with a up to 100 M of 3 (Figure S21). Despite 
this encouraging result, imaging of PPi with 3 in live HeLa cancer cells with either confocal 
microscopy or flow cytometry was impeded by the strong autoflourescence of HeLa cells at 
500 nm as shown in the supporting information (Figures S22-S24). To overcome this limitation, 
prove cellular uptake of the probe and its disassembly in the presence of endogenous PPi, we 
plan to develop and test improved disassembly based probes in the future. 
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In this work, we report on three FeIII-salen complexes containing a 3-chloro-5-imine-4-
hydroxybenzenesulfonic acid subunit and a modified diamine backbone. We demonstrated that 
two out of the three metal complexes are demetallated in the presence of (polyoxo)phosphate 
anions and hydrolyse subsequently into their molecular building blocks. The release of the 3-
chloro-5-formyl-4-hydroxybenzenesulfonic acid signaling unit is accompanied by a 
fluorometric response with an emission at 500 nm. Only one of the two probes was selective 
for PPi over sixteen other anions. This new probe with an 1,2-propanediamine backbone 
showed higher selectivity and better sensitivity for PPi compared to a prototype. In particular, 
the new derivative showed a 155-times better discrimination of PPi over ATP and a 2.3-times 
higher fluorescence upon disassembly. This probe was also successfully applied for sensing of 
PPi in foodstuff in a proof-of-principle study with baking powder. Studies with HeLa cells 
demonstrated that the probe was not suitable for cellular applications due to an overlap of the 
emission spectra of the compound with the high autofluorescence of HeLa cells. This 
observation has to be considered in future probe design.  
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